Gilead’s team of researchers and collaborators creates innovative medicines that advance the treatment of serious medical conditions. But improving health requires more than scientific discovery. As we grow as a company, so does our responsibility to the patients and communities we serve. 

We make it a priority to help ensure that our medicines are accessible to all people who need them, regardless of where they live or what resources they have. Gilead operates programs to expand access to medicines in the United States and the developing world. 

One of the biggest barriers to improving health is the diagnosis and linkage to appropriate medical care for individuals with life-threatening diseases like HIV/AIDS. We work with various partners throughout highly impacted communities to increase disease awareness, screening and linkages to care. 

Supporting our Community 

Our corporate giving programs provide support to U.S.-based healthcare and charitable activities related to our core therapeutic areas. We are also proud to support non-healthcare related social service, science and education, and community programs in the locations where Gilead operates.

Advancing Therapeutics, Improving Lives 

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, serious respiratory and cardiovascular conditions, cancer and inflammation. 

Our portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.

Strength Through Partnership 

Collaborations of all kinds – with partners in science, academia, business and local communities – are central to our work. Partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible. 

Growing Worldwide Reach 

Gilead was founded in 1987 in Foster City, California. In just over 25 years, we have grown to become one of the world’s largest biopharmaceutical companies, with approximately 6,400 employees across five continents.